Cite

HARVARD Citation

    Nicolet, C. et al. (n.d.). PO-1267 Pulmonary toxicities after chemoradiation followed by durvalumab for stage III NSCLC: a real setting. Radiotherapy and oncology. pp. S1069-S1070. [Online]. 
  
Back to record